Azithromycin for COVID-19: More Than Just an Antimicrobial?

Clin Drug Investig. 2020 Aug;40(8):683-686. doi: 10.1007/s40261-020-00933-3.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adult
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use*
  • Azithromycin / pharmacology
  • Azithromycin / therapeutic use*
  • COVID-19
  • COVID-19 Drug Treatment
  • Child
  • Coronavirus Infections / drug therapy*
  • Critical Care
  • Humans
  • Immunologic Factors / pharmacology
  • Immunologic Factors / therapeutic use
  • Pandemics
  • Pneumonia, Viral / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Antiviral Agents
  • Immunologic Factors
  • Azithromycin